ResMed Inc.
Net Cash Flow Breakdown
FY2026
FY2025
FY2024
FY2023
FY2022
FY2021
FY2020
FY2019
FY2018
FY2017
FY2016
FY2015
FY2014
FY2013
FY2012
FY2011
FY2010
FY2009
Total Cash from Operations: $1.88B
| Line Item | Value | % of Total |
|---|---|---|
| Capital Expenditures | $155.5M | 8.3% |
| Business Acquisitions | $349.0M | 18.6% |
| Other Investing | $38.0M | 2.0% |
| Dividends Paid | $349.7M | 18.6% |
| Stock Repurchases | $700.0M | 37.3% |
| Working Capital | $23.2M | 1.2% |
| Net Cash Flow | $259.8M | 13.9% |